Global Neuroblastoma Market Overview:
Global Neuroblastoma Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Neuroblastoma Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Neuroblastoma involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Neuroblastoma Market:
The Neuroblastoma Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Neuroblastoma Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Neuroblastoma Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Neuroblastoma market has been segmented into:
MIBG Scan
Imaging
and Biopsy
By Application, Neuroblastoma market has been segmented into:
Medications
Surgery
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Immunotherapy
and Monoclonal Antibody Treatment
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Neuroblastoma market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Neuroblastoma market.
Top Key Players Covered in Neuroblastoma market are:
Lonza Biologics Ltd
PerkinElmer Inc.
BD Biosciences
bioMerieux
Beckman Coulter Inc.
GE healthcare
EMD Chemicals Inc.
Meridian Life science Inc.
Shimadzu Biotech
Takara Bio Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Neuroblastoma Market Type
4.1 Neuroblastoma Market Snapshot and Growth Engine
4.2 Neuroblastoma Market Overview
4.3 MIBG Scan
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 MIBG Scan: Geographic Segmentation Analysis
4.4 Imaging
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Imaging: Geographic Segmentation Analysis
4.5 and Biopsy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 and Biopsy: Geographic Segmentation Analysis
Chapter 5: Neuroblastoma Market Application
5.1 Neuroblastoma Market Snapshot and Growth Engine
5.2 Neuroblastoma Market Overview
5.3 Medications
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Medications: Geographic Segmentation Analysis
5.4 Surgery
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Surgery: Geographic Segmentation Analysis
5.5 Chemotherapy
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Chemotherapy: Geographic Segmentation Analysis
5.6 Radiation Therapy
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Radiation Therapy: Geographic Segmentation Analysis
5.7 Stem Cell Transplant
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Stem Cell Transplant: Geographic Segmentation Analysis
5.8 Immunotherapy
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Immunotherapy: Geographic Segmentation Analysis
5.9 and Monoclonal Antibody Treatment
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 and Monoclonal Antibody Treatment: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Neuroblastoma Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 LONZA BIOLOGICS LTD
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 PERKINELMER INC.
6.4 BD BIOSCIENCES
6.5 BIOMERIEUX
6.6 BECKMAN COULTER INC.
6.7 GE HEALTHCARE
6.8 EMD CHEMICALS INC.
6.9 MERIDIAN LIFE SCIENCE INC.
6.10 SHIMADZU BIOTECH
6.11 TAKARA BIO INC.
Chapter 7: Global Neuroblastoma Market By Region
7.1 Overview
7.2. North America Neuroblastoma Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 MIBG Scan
7.2.2.2 Imaging
7.2.2.3 and Biopsy
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Medications
7.2.3.2 Surgery
7.2.3.3 Chemotherapy
7.2.3.4 Radiation Therapy
7.2.3.5 Stem Cell Transplant
7.2.3.6 Immunotherapy
7.2.3.7 and Monoclonal Antibody Treatment
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Neuroblastoma Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 MIBG Scan
7.3.2.2 Imaging
7.3.2.3 and Biopsy
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Medications
7.3.3.2 Surgery
7.3.3.3 Chemotherapy
7.3.3.4 Radiation Therapy
7.3.3.5 Stem Cell Transplant
7.3.3.6 Immunotherapy
7.3.3.7 and Monoclonal Antibody Treatment
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Neuroblastoma Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 MIBG Scan
7.4.2.2 Imaging
7.4.2.3 and Biopsy
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Medications
7.4.3.2 Surgery
7.4.3.3 Chemotherapy
7.4.3.4 Radiation Therapy
7.4.3.5 Stem Cell Transplant
7.4.3.6 Immunotherapy
7.4.3.7 and Monoclonal Antibody Treatment
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Neuroblastoma Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 MIBG Scan
7.5.2.2 Imaging
7.5.2.3 and Biopsy
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Medications
7.5.3.2 Surgery
7.5.3.3 Chemotherapy
7.5.3.4 Radiation Therapy
7.5.3.5 Stem Cell Transplant
7.5.3.6 Immunotherapy
7.5.3.7 and Monoclonal Antibody Treatment
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Neuroblastoma Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 MIBG Scan
7.6.2.2 Imaging
7.6.2.3 and Biopsy
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Medications
7.6.3.2 Surgery
7.6.3.3 Chemotherapy
7.6.3.4 Radiation Therapy
7.6.3.5 Stem Cell Transplant
7.6.3.6 Immunotherapy
7.6.3.7 and Monoclonal Antibody Treatment
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Neuroblastoma Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 MIBG Scan
7.7.2.2 Imaging
7.7.2.3 and Biopsy
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Medications
7.7.3.2 Surgery
7.7.3.3 Chemotherapy
7.7.3.4 Radiation Therapy
7.7.3.5 Stem Cell Transplant
7.7.3.6 Immunotherapy
7.7.3.7 and Monoclonal Antibody Treatment
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Neuroblastoma Scope:
|
Report Data
|
Neuroblastoma Market
|
|
Neuroblastoma Market Size in 2025
|
USD XX million
|
|
Neuroblastoma CAGR 2025 - 2032
|
XX%
|
|
Neuroblastoma Base Year
|
2024
|
|
Neuroblastoma Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Lonza Biologics Ltd, PerkinElmer Inc., BD Biosciences, bioMerieux, Beckman Coulter Inc., GE healthcare, EMD Chemicals Inc., Meridian Life science Inc., Shimadzu Biotech, Takara Bio Inc..
|
|
Key Segments
|
By Type
MIBG Scan
Imaging
and Biopsy
By Applications
Medications
Surgery
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Immunotherapy
and Monoclonal Antibody Treatment
|
